Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model

Regulation of angiogenesis through the efficient delivery of microRNAs into endothelial cells using polyamine-coated carbon nanotubes

(2016) Andrea Masotti et al.   Nanomedicine-Nanotechnology Biology and Medicine

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

(2016) Andrew W. Roberts et al.   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN

(2016) JIANSONG CHEN et al.   ONCOLOGY REPORTS

TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia

(2016) A Bresin et al.   Cell Death & Disease

In vivo delivery of miRNAs for cancer therapy: Challenges and strategies

(2015) Yunching Chen et al.   ADVANCED DRUG DELIVERY REVIEWS

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma

(2015) N. W. C. J. van de Donk et al.   BLOOD

Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia

(2015) X Zhu et al.   CANCER GENE THERAPY

A miR-130a-YAP positive feedback loop promotes organ size and tumorigenesis

(2015) Shuying Shen et al.   CELL RESEARCH

Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo

(2015) Cristian Taccioli et al.   JNCI-Journal of the National Cancer Institute

Mutations driving CLL and their evolution in progression and relapse

(2015) Dan A. Landau et al.   NATURE

miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3

(2015) HONG JIANG et al.   ONCOLOGY REPORTS

miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells

(2015) Yasunori Fujita et al.   PROSTATE

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model

(2015) Antonella Bresin et al.   Oncotarget

Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells

(2015) Sun Hee Lee et al.   Oncotarget

Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo

(2015) Cristian Taccioli et al.   JNCI-Journal of the National Cancer Institute

MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation

(2015) Yuhuang Li et al.   Oncotarget

Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy

(2014) G. Simonetti et al.   BLOOD

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

(2014) B. Cui et al.   BLOOD

Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries

(2014) E. Miotto et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters

(2014) M. Negrini et al.   CLINICAL CANCER RESEARCH

The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting

(2014) T Vaisitti et al.   LEUKEMIA

MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis

(2014) Binkui Li et al.   MEDICAL ONCOLOGY

Therapeutic targeting of microRNAs: current status and future challenges

(2014) Zhonghan Li et al.   NATURE REVIEWS DRUG DISCOVERY

In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma

(2014) Maria Teresa Di Martino et al.   PLoS One

Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma

(2014) Immacolata Scognamiglio et al.   Biomed Research International

Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups

(2014) Antonio Cuneo et al.   Cancer Medicine

Role of microRNA in the pathogenesis of malignant lymphoma

(2013) Hiroyuki Tagawa et al.   CANCER SCIENCE

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway

(2013) Xin Yang et al.   HEPATOLOGY

Progress in microRNA delivery

(2013) Yu Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Unknown

(2013) Antonella Chillemi et al.   MOLECULAR MEDICINE

The Oncogenic Role of microRNA-130a/301a/454 in Human Colorectal Cancer via Targeting Smad4 Expression

(2013) Lin Liu et al.   PLoS One

MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1

(2013) Jie Gao et al.   PLoS One

Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus

(2013) Elisa Callegari et al.   PLoS One

A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells

(2012) Rajib Ghosh et al.   BIOMATERIALS

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

(2012) Y. Zhang et al.   BLOOD

The Oncogenic Role of miR-155 in Breast Cancer

(2012) S. Mattiske et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells

(2012) V. Kovaleva et al.   CANCER RESEARCH

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

(2012) Ying Zhu et al.   NUCLEIC ACIDS RESEARCH

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

(2012) K Boll et al.   ONCOGENE

CD38 and chronic lymphocytic leukemia: a decade later

(2011) F. Malavasi et al.   BLOOD

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

(2011) K. Vargova et al.   BLOOD

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

(2011) D. Rossi et al.   BLOOD

miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia

(2011) R. Visone et al.   BLOOD

Lentivirus-Mediated Overexpression of MicroRNA-199a Inhibits Cell Proliferation of Human Hepatocellular Carcinoma

(2011) Xiao Qin Jia et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia

(2011) Muller Fabbri   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

(2010) P. Perez-Galan et al.   BLOOD

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival

(2010) S. Rossi et al.   BLOOD

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

(2010) Ulf Klein et al.   CANCER CELL

CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation

(2010) A Efanov et al.   LEUKEMIA

Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

(2010) H. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Karyotype-specific microRNA signature in chronic lymphocytic leukemia

(2009) R. Visone et al.   BLOOD

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

(2009) Janaiah Kota et al.   CELL

The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

(2009) J. T. Huse et al.   GENES & DEVELOPMENT

Regulated and Multiple miRNA and siRNA Delivery Into Primary Cells by a Lentiviral Platform

(2009) Mario Amendola et al.   MOLECULAR THERAPY

MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

(2009) Junfang Ji et al.   NEW ENGLAND JOURNAL OF MEDICINE

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

(2008) S. Sander et al.   BLOOD

MicroRNAs in normal and malignant hematopoiesis

(2008) Ramiro Garzon et al.   CURRENT OPINION IN HEMATOLOGY

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

(2008) Ryan M. O'Connell et al.   JOURNAL OF EXPERIMENTAL MEDICINE

LNA-mediated microRNA silencing in non-human primates

(2008) Joacim Elmén et al.   NATURE

Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology

(2008) Fabio Malavasi et al.   PHYSIOLOGICAL REVIEWS